Once-weekly REZZAYO® (rezafungin for injection) may simplify your invasive candidiasis infusion treatment
What is REZZAYO®?
REZZAYO® is an antifungal medication used to treat candidemia and invasive candidiasis, which are infections in the bloodstream or internal organs caused by a yeast (fungus) called Candida.
REZZAYO® is approved for adults 18 years of age or older who have limited or no alternative options for the treatment of candidemia and invasive candidiasis. FDA approval of REZZAYO® was based on limited clinical safety and effectiveness data. REZZAYO® has not been studied in patients with Candida infections of the heart (endocarditis), bone (osteomyelitis), or brain and spinal cord (meningitis).
IMPORTANT SAFETY INFORMATION
Do not take REZZAYO® if you are allergic to rezafungin or other echinocandins.
Actor Portrayal
Simplify your treatment with once-weekly REZZAYO®
There are many other echinocandin infusion treatments you may have heard of, such as caspofungin, micafungin, and anidulafungin, but REZZAYO® is different because it is dosed once-weekly.
In clinical trials with over 200 adults with candidemia and invasive candidiasis, once-weekly REZZAYO® was shown to be as effective as a daily infusion of caspofungin.
The most common side effects of REZZAYO® are fever, diarrhea, anemia, vomiting, nausea, stomach pain, constipation, and low levels of potassium, magnesium, or phosphate in the blood. Please see Important Safety Information below and full Prescribing Information.
As you can see in the chart below, with REZZAYO®, an infusion is needed only once a week—rather than daily—making it easier to fit into your schedule.
|
Once-weekly REZZAYO® |
|
No PICC |
||||||||||||||||
|
VS |
||||||||||||||||||
|
Daily IV echinocandin |
|
Daily PICC |
*Unlike daily IV antifungal treatment, REZZAYO® does not require what is called a central IV line (often referred to as a PICC line), which is a long, thin tube that must be inserted into the arm for an extended period of time in order to administer the drug.
If you’ve been prescribed a daily antifungal infusion, such as caspofungin, micafungin, or anidulafungin, there are a few questions you may want to ask your healthcare team:
Are there other treatment options that don’t need to be taken so often?
Can I avoid
a PICC line?
Do I have to go to
an infusion center every day?
Here are a few reasons why you may want to talk to your healthcare team about once-weekly REZZAYO®:
One IV infusion once a week for 1 hour
REZZAYO® can be given at the hospital, at an infusion center, or at home by a nurse
REZZAYO® does not require a central IV line or PICC*
Copay assistance may be available for eligible patients with private commercial insurance—ask your healthcare team for information†
REZZAYO® can be taken safely with other commonly prescribed medications
Once-weekly REZZAYO® is the first FDA-approved treatment of its kind in over 15 years
*Unlike daily IV antifungal treatment, REZZAYO® does not require what is called a central IV line (often referred to as a PICC line), which is a long, thin tube that must be inserted into the arm for an extended period of time in order to administer the drug.
†A patient will not qualify if they have a prescription drug benefit through a government program (ie, Medicaid, Medicare, Medicare Part D, Medigap, CHAMPUS, DOD, VA, TRICARE, or any state patient or pharmaceutical assistance program).
As a condition for receiving copays or coinsurance, both healthcare professionals and patients are required to inform patients’ insurance companies and third-party payers of any copays or coinsurance benefits paid by this program.
Void where prohibited by law, taxed, or restricted. Additional terms and conditions may apply. Patients enrolled in the REZZAYO® Patient Assistance Program are not eligible. Melinta Therapeutics, LLC may determine eligibility, monitor participation, and modify or discontinue any aspect of this program at any time.
Talk to your healthcare team today about once-weekly REZZAYO® to see if it’s right for you
Actor Portrayal